Susan Wolver, M.D., medical director of the VCU Health Medical Weight Loss Program, has been prescribing GLP-1 receptor agonists since they were first approved by the U.S
GLP-1 medications begin working at the molecular level within hours, activating receptors in the brain and gut
Efficacy and Safety of Liraglutide and Semaglutide on Weight Loss in People With Obesity or Overweight: A Systematic Review
In our practice, constipation is one of the most consistently reported problems on GLP-1 therapy, particularly in the first weeks of a new dose
Silva may divide your weekly dose into two smaller injections, delivering the same total amount in a gentler, more tolerable pattern
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats